CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later) 		 
     
 
 
 
Wuhan Mayinglong Pharmaceutical Group Stock Co.,Ltd Company Snapshot
Business Description:
Wuhan Mayinglong Pharmaceutical Group Stock Co.,Ltd operates in the Pharmaceutical preparations sector. Mayinglong Pharmaceutical Group Co,.LTD is principally engaged in pharmaceutical production, wholesaling and retailing businesses. The Company's pharmaceutical products are classified as drugs for hemorrhoid, including diosmin tablets, suppositories, pastes and granules, among others; drugs for colpitis, including metronidazole suppositories and clotrimazole suppositories; drugs for cough, including levodropropizine oral solution and compound glycyrrhiza oral solution, as well as drugs for skin injuries, including products such as erythromycin ointment. The Company also involves in production and distribution of eye cream products with the brand named Mayinglong BaBao, as well as operation of hospitals. The Company distributes its products primarily in domestic market. In our complete report available for purchase the company is compared to: ChangChun High New Technology Industries, Tianjin Tianyao Pharmaceutical, Ltd. and Jilin Aodong Medicine Industry (Group) Co., Ltd..
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Wuhan Mayinglong Pharmaceutical Group Stock Co.,Ltd
  Stock Performance Chart for Wuhan Mayinglong Pharmaceutical Group Stock Co.,Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (2/3/2012): 15.23
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks -1.6%  
4 Weeks -18.7%   52 Weeks -20.6%  
 
Wuhan Mayinglong Pharmaceutical Group Stock Co.,Ltd Key Data:
  Ticker: 600993 Country: CHINA
  Exchanges: SHG Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Ethical Drug Manufacturers
  2010 Sales 1,178,495,000
(Year Ending Jan 2011).		 Employees: 1,254
  Currency: Chinese Renmimbi Market Cap: 5,049,962,121
  Fiscal Yr Ends: December Shares Outstanding: 331,579,916
  Share Type: A Shares Closely Held Shares: N/A
 
 
Featured Products and Services
  
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.